Source: The Pharma Letter

Avista Pharma: Cambrex to acquire Avista Pharma Solutions

In what is a second buy this year for the company, Cambrex Corp (NYSE: CBM), a manufacturer of active...

Read full article »
Avista Pharma's Competitors | Avista Pharma's News | Avista Pharma's Financials
Stay up-to-date with the latest news on Avista Pharma Solutions, Inc.
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Patrick D. Walsh's photo - CEO of Avista Pharma Solutions, Inc.

CEO

Patrick D. Walsh

CEO Approval Rating

86/100

Read more
Stay up-to-date with the latest news on Avista Pharma Solutions, Inc.